Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Jayachandran Perumal Kalaiyarasi, Prasanth Ganesan, Krishnarathinam Kannan, Trivadi S. Ganesan, Venkatraman Radhakrishnan, Manikandan Dhanushkodi, S. Krupashankar, Nikita Mehra, Tenali Gnana Sagar

ABSTRACT

Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (≥ 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60–90 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5–3 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18–66) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3–ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don’t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes. More... »

PAGES

248-254

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0

DOI

http://dx.doi.org/10.1007/s12288-018-1023-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107349516


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalaiyarasi", 
        "givenName": "Jayachandran Perumal", 
        "id": "sg:person.011770565440.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Prasanth", 
        "id": "sg:person.0716343050.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kannan", 
        "givenName": "Krishnarathinam", 
        "id": "sg:person.0657501276.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Trivadi S.", 
        "id": "sg:person.01354150255.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radhakrishnan", 
        "givenName": "Venkatraman", 
        "id": "sg:person.010316745623.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dhanushkodi", 
        "givenName": "Manikandan", 
        "id": "sg:person.01225301441.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krupashankar", 
        "givenName": "S.", 
        "id": "sg:person.010131407614.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010131407614.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehra", 
        "givenName": "Nikita", 
        "id": "sg:person.013004716016.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sagar", 
        "givenName": "Tenali Gnana", 
        "id": "sg:person.015576370407.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1182/blood-2010-07-295279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010761932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjh.13406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017282100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhin.2016.04.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024916616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1010222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030828053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1658-3876(08)50023-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031018815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2015/710543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031328730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-09-179341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032016811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.48.6886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034141191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.47.4874", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034938389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-07-657403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036230934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0904544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036718725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.7303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036777863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ajco.12333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040889000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-07-235358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042177075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-01-623447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049798638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082058251", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (\u2265 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60\u201390 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5\u20133 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18\u201366) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3\u2013ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don\u2019t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12288-018-1023-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1107805", 
        "issn": [
          "0971-4502", 
          "0974-0449"
        ], 
        "name": "Indian Journal of Hematology and Blood Transfusion", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "name": "Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre", 
    "pagination": "248-254", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e97a72506db560a4c5b4f166648d156a3c09339337173d2b07f440eed26a17d8"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12288-018-1023-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107349516"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12288-018-1023-0", 
      "https://app.dimensions.ai/details/publication/pub.1107349516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78944_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12288-018-1023-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-1023-0'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      43 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12288-018-1023-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N3fcc6fb1f9414ae0a07a89cd8c0ae7be
4 schema:citation https://app.dimensions.ai/details/publication/pub.1082058251
5 https://doi.org/10.1016/j.jhin.2016.04.012
6 https://doi.org/10.1016/s1658-3876(08)50023-9
7 https://doi.org/10.1056/nejmoa0904544
8 https://doi.org/10.1056/nejmoa1010222
9 https://doi.org/10.1111/ajco.12333
10 https://doi.org/10.1111/bjh.13406
11 https://doi.org/10.1155/2015/710543
12 https://doi.org/10.1182/blood-2008-09-179341
13 https://doi.org/10.1182/blood-2009-07-235358
14 https://doi.org/10.1182/blood-2010-07-295279
15 https://doi.org/10.1182/blood-2015-01-623447
16 https://doi.org/10.1182/blood-2015-07-657403
17 https://doi.org/10.1200/jco.2010.33.7303
18 https://doi.org/10.1200/jco.2012.47.4874
19 https://doi.org/10.1200/jco.2013.48.6886
20 schema:datePublished 2019-04
21 schema:datePublishedReg 2019-04-01
22 schema:description Background: Acute Myeloid Leukemia (AML) is a very aggressive cancer with difficult treatment and poor outcomes. The treatment of these patients is quite challenging due to various reasons including the need for extensive supportive care, and high cost of therapy. Reports on outcomes from India are few. Methods: We analyzed 93 adult patients (≥ 18 years) with AML who were treated with curative intent between 2007 and 2014. Patients received daunorubicin at dose of 60–90 mg/m2 and cytarabine 100 mg/m2 during induction and consolidation with 3 courses of high dose cytarabine (1.5–3 g/m2per dose for 6 doses per cycle). Only 4 patients underwent consolidation allogenic stem cell transplantation in first remission (CR1). Results: The median age was 37 (18–66) years; males: 52%. Conventional cytogenetics (N = 63) showed 23% (N = 15), 56% (N = 35), 27% (N = 13) in good, intermediate risk and poor risk category respectively. FLT3–ITD was positive in 12/33 (36%) and NPM mutation in 7/23 (30%). Daunorubicin dose was 60 mg/m2 in 75% (N = 70) and 90 mg/m2 in 25% (N = 23) patients. Induction mortality was 17% (16/93) [60 mg/m2:19% (13/70), and 90 mg/m2:13% (3/23); p = 0.39)]. Complete remission was achieved by 60% (56/93) [60 mg/m2:53% (37/70), and 90 mg/m2:83% (19/23); p = 0.09)]. The median overall survival was 9.2 months and the actuarial survival at 2 years was 30%. By univariate analysis, FLT3-ITD positivity, white cell counts higher than 100,000/mm3 at presentation, and use of lower dose of daunorubicin in induction were associated with poorer outcomes. Conclusions: Outcomes in adult AML are generally poor. Many patients with high risk disease don’t receive allogenic transplantation in CR1. Increased availability of allogenic stem cell transplantation may help to improve outcomes.
23 schema:genre research_article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf Ncd04fac0155c4c6981dac580b6257ff4
27 Nd58e7e8794ab4613809dfe42e29802ab
28 sg:journal.1107805
29 schema:name Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre
30 schema:pagination 248-254
31 schema:productId N8b2deb0279754e989511d383f2432821
32 Nac89753ba89242219b8dee326af90bc1
33 Nbb2efceef64444e3aa574bbc7cddb60e
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107349516
35 https://doi.org/10.1007/s12288-018-1023-0
36 schema:sdDatePublished 2019-04-11T13:18
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N54022d496c8a4b8b9cd71327a4ac1bb0
39 schema:url https://link.springer.com/10.1007%2Fs12288-018-1023-0
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N2c106f334e6444eabad64e14e05b6f15 rdf:first sg:person.01225301441.63
44 rdf:rest N2eb868c57ea24712a46360b4d3be33e0
45 N2eb868c57ea24712a46360b4d3be33e0 rdf:first sg:person.010131407614.15
46 rdf:rest Na7b19f3608c54adc98ee8a22f96d1823
47 N3fcc6fb1f9414ae0a07a89cd8c0ae7be rdf:first sg:person.011770565440.24
48 rdf:rest N428c143bb3704bb4b3f50951bb7bd90f
49 N428c143bb3704bb4b3f50951bb7bd90f rdf:first sg:person.0716343050.48
50 rdf:rest Nd069d1d119b34bd1972e58a891e8303e
51 N54022d496c8a4b8b9cd71327a4ac1bb0 schema:name Springer Nature - SN SciGraph project
52 rdf:type schema:Organization
53 N567846f1693d425c89ff3a370da7cc32 rdf:first sg:person.010316745623.36
54 rdf:rest N2c106f334e6444eabad64e14e05b6f15
55 N8b2deb0279754e989511d383f2432821 schema:name doi
56 schema:value 10.1007/s12288-018-1023-0
57 rdf:type schema:PropertyValue
58 N9d8712c8f88b4d23b15a35224f0ff952 rdf:first sg:person.01354150255.82
59 rdf:rest N567846f1693d425c89ff3a370da7cc32
60 N9dbf697771004bb0843cce18fce295af rdf:first sg:person.015576370407.55
61 rdf:rest rdf:nil
62 Na7b19f3608c54adc98ee8a22f96d1823 rdf:first sg:person.013004716016.82
63 rdf:rest N9dbf697771004bb0843cce18fce295af
64 Nac89753ba89242219b8dee326af90bc1 schema:name readcube_id
65 schema:value e97a72506db560a4c5b4f166648d156a3c09339337173d2b07f440eed26a17d8
66 rdf:type schema:PropertyValue
67 Nbb2efceef64444e3aa574bbc7cddb60e schema:name dimensions_id
68 schema:value pub.1107349516
69 rdf:type schema:PropertyValue
70 Ncd04fac0155c4c6981dac580b6257ff4 schema:volumeNumber 35
71 rdf:type schema:PublicationVolume
72 Nd069d1d119b34bd1972e58a891e8303e rdf:first sg:person.0657501276.96
73 rdf:rest N9d8712c8f88b4d23b15a35224f0ff952
74 Nd58e7e8794ab4613809dfe42e29802ab schema:issueNumber 2
75 rdf:type schema:PublicationIssue
76 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
77 schema:name Medical and Health Sciences
78 rdf:type schema:DefinedTerm
79 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
80 schema:name Oncology and Carcinogenesis
81 rdf:type schema:DefinedTerm
82 sg:journal.1107805 schema:issn 0971-4502
83 0974-0449
84 schema:name Indian Journal of Hematology and Blood Transfusion
85 rdf:type schema:Periodical
86 sg:person.010131407614.15 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
87 schema:familyName Krupashankar
88 schema:givenName S.
89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010131407614.15
90 rdf:type schema:Person
91 sg:person.010316745623.36 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
92 schema:familyName Radhakrishnan
93 schema:givenName Venkatraman
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36
95 rdf:type schema:Person
96 sg:person.011770565440.24 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
97 schema:familyName Kalaiyarasi
98 schema:givenName Jayachandran Perumal
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24
100 rdf:type schema:Person
101 sg:person.01225301441.63 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
102 schema:familyName Dhanushkodi
103 schema:givenName Manikandan
104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63
105 rdf:type schema:Person
106 sg:person.013004716016.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
107 schema:familyName Mehra
108 schema:givenName Nikita
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82
110 rdf:type schema:Person
111 sg:person.01354150255.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
112 schema:familyName Ganesan
113 schema:givenName Trivadi S.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82
115 rdf:type schema:Person
116 sg:person.015576370407.55 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
117 schema:familyName Sagar
118 schema:givenName Tenali Gnana
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55
120 rdf:type schema:Person
121 sg:person.0657501276.96 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
122 schema:familyName Kannan
123 schema:givenName Krishnarathinam
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96
125 rdf:type schema:Person
126 sg:person.0716343050.48 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
127 schema:familyName Ganesan
128 schema:givenName Prasanth
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48
130 rdf:type schema:Person
131 https://app.dimensions.ai/details/publication/pub.1082058251 schema:CreativeWork
132 https://doi.org/10.1016/j.jhin.2016.04.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024916616
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1016/s1658-3876(08)50023-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031018815
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1056/nejmoa0904544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036718725
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1056/nejmoa1010222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030828053
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1111/ajco.12333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040889000
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1111/bjh.13406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017282100
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1155/2015/710543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031328730
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1182/blood-2008-09-179341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032016811
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1182/blood-2009-07-235358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042177075
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1182/blood-2010-07-295279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010761932
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1182/blood-2015-01-623447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049798638
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1182/blood-2015-07-657403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036230934
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1200/jco.2010.33.7303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036777863
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1200/jco.2012.47.4874 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034938389
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1200/jco.2013.48.6886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034141191
161 rdf:type schema:CreativeWork
162 https://www.grid.ac/institutes/grid.418600.b schema:alternateName Cancer Institute
163 schema:name Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu, India
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...